The BCN and our Accelerated Access Collaborative (AAC) are working together, to better understand findings of innovative work, collaborative processes and good practice that has happened at the front line in response to COVID-19 within health and social care. This collaboration helps identify and prioritise the high-impact changes to sustain for the future, through evaluation, shared understanding and lessons learnt.
The AAC brings together industry, government, regulators, patients and the NHS to remove barriers and accelerate the introduction of ground-breaking new treatments and diagnostics which can transform care. The AAC supports all types of innovations: medicines, diagnostics, devices, digital products, pathway changes and new workforce models.
BCN and AAC Jointly commissioned review
The Accelerated Access Collaborative and Beneficial Changes Network have jointly-commissioned an independent review into research, innovation and partnership working in relation to the pandemic response, the results are due in the 2021. The review aims to understand the impact of the response to the pandemic in relation to health innovation, health research and partnership working across health and care.
Evaluation of promising high impact beneficial changes
To apply a thorough and robust evidence base to support any hopeful high impact changes, the Beneficial Changes Network and Accelerated Access Collaborative are supporting the partnership between the National Institute for Health Research, Applied Research Collaborations and the Academic Health Science Networks based in regions across England. This is to advance the regional prioritisation of promising high-impact beneficial changes, including interventions, technologies and tools, deployed during the pandemic.
The Beneficial Changes workstreams collated list of potential beneficial high-impact changes will inform this work. Access to the evidence already gathered by Beneficial Changes Network can be gained by contacting the Beneficial Changes Network team at email@example.com
The Applied Research Collaborations will work with their local Academic Health Science Networks to prioritise requests in each region, working with NHS England and NHS Improvement regional leads and Medical Directors to focus on strategic need. The aim is to achieve a manageable number of promising high impact changes, synthesising and sharing existing evidence, identifying potential evidence gaps and defining questions for further research and/or evaluation. There will be a particular focus on understanding and reducing any impact on health inequalities which may arise from any possible change.
The results of this stage of evaluation are expected in 2021.
The National Institute for Health Research and the Applied Research Collaborations will then take forward research priorities, from the manageable list of promising high impact changes that have wide applicability beyond the region. This will support implementation of new ways of working, based on the evidence provided.
The results of this stage to the research and evaluation will start to become available in 2021.